US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

9.45

+0.14001.50%

Post-market: 9.450.00000.00%16:19 EDT

Volume:183.74K

Turnover:1.73M

Market Cap:467.77M

PE:-8.18

High:9.51

Open:9.43

Low:9.30

Close:9.31

Loading ...

Overview Company News Filings

Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock?

Theravance Biopharma Up Nearly 9%, On Track for Largest Percent Increase Since April 2022 -- Data Talk

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Analysts Are Optimistic We'll See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH)

Simply Wall St.

Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable

Simply Wall St.

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

Theravance Biopharma Up Over 10%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

Theravance Biopharma (TBPH) Receives a Hold from Evercore ISI

Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...

Balanced View on Theravance Biopharma: Strong Growth Amidst Financial Challenges and Strategic Uncertainty

Theravance Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary

Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates

Theravance Biopharma Q3 2024 Adj. EPS $(0.26) Misses $(0.23) Estimate, Sales $16.900M Beat $15.344M Estimate

BRIEF-Theravance Biopharma Q3 Operating Income USD -10.837 Million

Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value

THOMSON REUTERS

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TBPH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBPH\",,,,,undefined,":{"symbol":"TBPH","market":"US","secType":"STK","nameCN":"Theravance Biopharma","latestPrice":9.45,"timestamp":1745438400000,"preClose":9.31,"halted":0,"volume":183736,"hourTrading":{"tag":"盘后","latestPrice":9.45,"preClose":9.45,"latestTime":"16:19 EDT","volume":10373,"amount":98024.84999999999,"timestamp":1745439599428},"delay":0,"floatShares":21451216,"shares":49500000,"eps":-1.154994,"marketStatus":"Post-Mkt","change":0.14,"latestTime":"04-23 16:36:49 EDT","open":9.43,"high":9.51,"low":9.3,"amount":1731078.5611,"amplitude":0.022556,"askPrice":9.53,"askSize":30,"bidPrice":8.38,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.154994,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1400212800000,"exchange":"NASDAQ","adjPreClose":9.31,"preHourTrading":{"tag":"盘前","latestPrice":9.22,"preClose":9.31,"latestTime":"04:21 EDT","volume":1,"amount":9.22,"timestamp":1745396460340},"postHourTrading":{"tag":"盘后","latestPrice":9.45,"preClose":9.45,"latestTime":"16:19 EDT","volume":10373,"amount":98024.84999999999,"timestamp":1745439599428},"volumeRatio":0.831727,"impliedVol":0.3822,"impliedVolPercentile":0.276},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBPH\",,,,,undefined,":{"symbol":"TBPH","floatShares":21451216,"roa":"-7.21%","roe":"-29.04%","lyrEps":-1.154994,"volumeRatio":0.831727,"shares":49500000,"dividePrice":0,"high":9.51,"amplitude":0.022556,"preClose":9.31,"low":9.3,"week52Low":7.44,"pbRate":"2.66","psRate":"7.27","week52High":10.9,"institutionHeld":0,"latestPrice":9.45,"committee":0.538462,"eps":-1.154994,"divideRate":0,"volume":183736,"delay":0,"ttmEps":-1.154994,"open":9.43,"prevYearClose":9.41,"prevWeekClose":8.62,"prevMonthClose":8.93,"prevQuarterClose":8.93,"fiveDayClose":8.63,"twentyDayClose":9.31,"sixtyDayClose":9.67},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBPH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506222243","title":"Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506222243","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506222243?lang=en_us&edition=fundamental","pubTime":"2025-01-27 16:57","pubTimestamp":1737968220,"startTime":"0","endTime":"0","summary":"Theravance Biopharma  shares ended the last trading session 8.3% higher at $10.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 1.9% loss over the past four weeks.The company has developed Yupelri, a nebulized treatment for chronic obstructive pulmonary disease, in collaboration with Viatris. Theravance is also developing ampreloxetine in late-stage studies for treating neurogenic orthostatic hypotension in patients with multiple system atrophy. The growing optimism related to encouraging pipeline progress, along with the uptake of Yupelri, might have driven the recent share price rally.This biopharmaceutical company is expected to post quarterly loss of $0.05 per share in its upcoming report, which represents a year-over-year change of -266.7%. Revenues are expected to be $35.19 million, up 100.3% from the year-ago quarter.Theravance Bio is a member of the Zacks Medical - Drugs industry. O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-bio-tbph-soars-8-085700245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ECOR","TBPH","BK4007","BK4082"],"gpt_icon":0},{"id":"2506894117","title":"Theravance Biopharma Up Nearly 9%, On Track for Largest Percent Increase Since April 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894117","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506894117?lang=en_us&edition=fundamental","pubTime":"2025-01-25 03:01","pubTimestamp":1737745260,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc.  is currently at $10.52, up $0.85 or 8.79%. --Would be highest close since Jan. 4, 2024, when it closed at $11.52. --On pace for largest percent increase since April 25, 2022, when it rose 9.39%. --Currently up five consecutive days; up 24.64% over this period. --Longest winning streak since Nov. 11, 2024, when it rose for five straight trading days. --Up 11.8% month-to-date; on pace for best month since Nov. 2024, when it rose 12.26%. --Down 75.28% from its all-time closing high of $42.56 on July 7, 2017. --Up 6.16% from 52 weeks ago , when it closed at $9.91. --Up 37.34% from its 52-week closing low of $7.66 on Aug. 9, 2024. --Traded as high as $10.90; highest intraday level since Jan. 4, 2024, when it hit $11.71. --Up 12.72% at today's intraday high; largest intraday percent increase since Nov. 13, 2024, when it rose as much as 15.15%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2504010332","title":"Ozempic, Xtandi among next 15 drugs selected for U.S. price talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2504010332","media":"TipRanks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504010332?lang=en_us&edition=fundamental","pubTime":"2025-01-18 21:20","pubTimestamp":1737206448,"startTime":"0","endTime":"0","summary":"The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations. In accordance with the Inflation Reduction Act, the negotiations with participating drug companies for these 15 drugs will occur in 2025 and any negotiated prices will become effective in 2027, the agency said in a statement. The selected drug list for the second cycle of negotiations is: Novo Nordisk’s  Ozempic, Rybelsus, and Wegovy, GSK‘s  Trelegy Ellipta, Pfizer’s  Xtandi, Bristol Myers’  Pomalyst, Pfizer’s  Ibrance, Boehringer Ingleheim’s Ofev, AbbVie  and Ironwood’s  Linzess, AstraZeneca’s  Calquence, Teva‘s  Austedo, GSK and Theravance’s  Breo Ellipta, Boehringer’s Tradjenta, Salix’s  Xifaxan, AbbVie’s Vraylar, Merck’s  Janumet, and Amgen’s  Otezla. Companies with a selected drug will have until February 28 to decide if they will participate in negotiations.Discover outperforming sto","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ozempic-xtandi-among-next-15-132048211.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ozempic-xtandi-among-next-15-132048211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH","SG9999002232.USD","LU2023250843.SGD","MRK","GSK.UK","IE00B42XCP33.USD","LU1941712348.USD","BK4581","LU1989771016.USD","AMGN","LU0256863902.USD","LU1571399168.USD","LU2462157665.USD","LU1323610961.USD","LU2023250504.SGD","LU1037948541.HKD","LU2461242641.AUD","LU0417517546.SGD","SG9999015952.SGD","SGXZ57979304.SGD","LU0320765489.SGD","ABBV","LU0029864427.USD","LU0234570918.USD","LU1699723380.USD","IE00B19Z3B42.SGD","IE00B3PB1722.GBP","BMY","BHC","LU2361045086.USD","IE00B2B36J28.USD","LU0109394709.USD","IE00BVYPNV92.GBP","GSK","LU2236285917.USD","NVO","LU1003077747.HKD","IRWD","PFE","SG9999001440.SGD","SG9999014575.USD","SG9999003800.SGD","LU2237443622.USD","LU2468319806.SGD","TEVA","LU2417539215.USD","LU0256863811.USD","AZN","LU0306807586.USD","IE00BDGV0183.EUR"],"gpt_icon":1},{"id":"2501786737","title":"Analysts Are Optimistic We'll See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501786737","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501786737?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:04","pubTimestamp":1736255093,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at Theravance Biopharma, Inc.'s  future prospects. Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. The US$458m market-cap company’s loss lessened since it announced a US$55m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$49m, as it approaches breakeven. The most pressing concern for investors is Theravance Biopharma's path to profitability – when will it breakeven?In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.Using a line of best fit, we calculated an average annual growth rate of 66%, which is rather optimistic!Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analysts-optimistic-well-see-profit-130453864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKPKM429.USD","LU2095319765.USD","SQQQ","BK4112","IE00B3QW5Z07.USD","NQmain","IE00B64PRP62.GBP","USAW.SI","QLD","QID","USJW.SI","MNQmain","LU2210150020.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4007","TBPH","TQQQ","BK4588","BK4585","PSQ","TSYW.SI",".IXIC","NDAQ","NVIW.SI"],"gpt_icon":1},{"id":"2491033201","title":"Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=2491033201","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491033201?lang=en_us&edition=fundamental","pubTime":"2024-12-13 00:30","pubTimestamp":1734021030,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Theravance Biopharma . Shares have added about 3.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Theravance Bio due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.Theravance Q3 Loss Narrower Than Expected, Revenues Rise Y/Y. Theravance reported third-quarter 2024 adjusted net loss of 6 cents per share, narrower than the Zacks Consensus Estimate of a loss of 10 cents. In the year-ago quarter, the company had incurred an adjusted loss of 1 cent per share.The reported loss excludes share-based compensation expense, non-cash impairment of long-lived assets, income tax expense and non-cash interest expense. Including these items, the company reported a loss of 26 cents per share in the thi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-bio-tbph-3-7-163030730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH","IONS"],"gpt_icon":1},{"id":"2490851088","title":"The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable","url":"https://stock-news.laohu8.com/highlight/detail?id=2490851088","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490851088?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:37","pubTimestamp":1733920667,"startTime":"0","endTime":"0","summary":"While it may not be enough for some shareholders, we think it is good to see the Theravance Biopharma, Inc.  share price up 24% in a single quarter. But that can't change the reality that over the longer term , the returns have been really quite dismal. The share price has failed to impress anyone , down a sizable 56% during that time. So we're hesitant to put much weight behind the short term increase. However, in the best case scenario , this improved performance might be sustained.Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.In the last five years Theravance Biopharma saw its revenue shrink by 6.8% per year. While far from catastrophic that is not good. The share price decline of 9% compound, over five years, is understandable given the company is losing money, and revenue is moving in the wrong direction. The chance of imminent investor enthusiasm for this stock seems slimmer ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/past-five-years-theravance-biopharma-123747409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","LU2210149790.SGD","MNQmain","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NQmain","SQQQ","BK4112","QID","LU2210150020.SGD","BK4588","BK4007","IE00BKPKM429.USD","TBPH","QLD","NDAQ","IE00B64PRP62.GBP","PSQ","TQQQ",".IXIC","BK4585"],"gpt_icon":1},{"id":"2484196091","title":"Theravance Biopharma to Participate in an Upcoming Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2484196091","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484196091?lang=en_us&edition=fundamental","pubTime":"2024-11-20 19:00","pubTimestamp":1732100400,"startTime":"0","endTime":"0","summary":"DUBLIN, Nov. 20, 2024 /PRNewswire/ -- Theravance Biopharma, Inc.  will participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference on Tuesday, December 3 at 11:15 am EST  and will be hosting in-person meetings with the investment community at the conference.Webcast of the event may be accessed by visiting Theravance.com, under the Investors section, Events and Presentations. Replay of the webcast will be archived on the Company's website for 30 days.Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI  inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease . Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension  in patients ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Dw8PO_lLOR.U3aZvl_25yw--~B/aD05NDt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/4d2df003249986704ef2ebec0198a9bd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Dw8PO_lLOR.U3aZvl_25yw--~B/aD05NDt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/4d2df003249986704ef2ebec0198a9bd"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/theravance-biopharma-participate-upcoming-investor-110000423.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-participate-upcoming-investor-110000423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MSA","LU2125909916.SGD","LU1815336091.USD","LU0053671581.USD","BK4143","TBPH","LU0757428866.USD","LU2125909759.SGD","BK4007","LU0728928796.USD","LU1923622291.USD"],"gpt_icon":1},{"id":"2483729778","title":"Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2483729778","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483729778?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:20","pubTimestamp":1731586800,"startTime":"0","endTime":"0","summary":"NasdaqGM:TBPH Earnings and Revenue History November 14th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 9.4%. Earnings per share  missed analyst estimates by 13%.Looking ahead, revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in the US.The company's shares are up 11% from a week ago.Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Theravance Biopharma's balance sheet health.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-third-quarter-2024-122000397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH"],"gpt_icon":0},{"id":"2483883154","title":"Theravance Biopharma Up Over 10%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2483883154","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483883154?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:56","pubTimestamp":1731516960,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc  is currently at $9.85, up $0.94 or 10.49%. --Would be highest close since Aug. 1, 2024, when it closed at $10.03. --On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13%. --Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82%. --Down 76.87% from its all-time closing high of $42.56 on July 7, 2017. --Down 3.76% from 52 weeks ago , when it closed at $10.23. --Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024. --Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35. --Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2483858849","title":"Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2483858849","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483858849?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:28","pubTimestamp":1731515280,"startTime":"0","endTime":"0","summary":"Theravance Biopharma TBPH reported third-quarter 2024 adjusted net loss of 6 cents per share, narrower than the Zacks Consensus Estimate of a loss of 10 cents. In the year-ago quarter, the company had incurred an adjusted loss of 1 cent per share.The reported loss excludes share-based compensation expense, non-cash impairment of long-lived assets, income tax expense and non-cash interest expense. Including these items, the company reported a loss of 26 cents per share in the third quarter compared with a loss of 17 cents in the year-ago quarter.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Research and development expenses  totaled $8.2 million, up almost 30% from the year-ago quarter’s level. Selling, general and administrative expenses  increased around 10% year over year to $13 million.Theravance continues to expect adjusted R&D expenses  in the $30-$36 million range. Adjusted SG&A expenses  are projected between $45 million and $55 million.Theravance is dev","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uOZ0xCMyYNsiY87_fI2kLQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/81880a99f954ad6a8713d0d282dde701","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uOZ0xCMyYNsiY87_fI2kLQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/81880a99f954ad6a8713d0d282dde701"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravances-q3-loss-narrower-expected-162800318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH","VTRS"],"gpt_icon":0},{"id":"2483888845","title":"Theravance Biopharma (TBPH) Receives a Hold from Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2483888845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483888845?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:38","pubTimestamp":1731505092,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Liisa Bayko maintained a Hold rating on Theravance Biopharma (TBPH – Research Report) today and set a price target of $11.00. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/theravance-biopharma-tbph-receives-a-hold-from-evercore-isi-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/theravance-biopharma-tbph-receives-a-hold-from-evercore-isi-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2483258650","title":"Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483258650","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483258650?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:22","pubTimestamp":1731482533,"startTime":"0","endTime":"0","summary":"Quarterly Net Sales: $62.2 million, a 7% year-over-year growth and 14% quarter-on-quarter increase.Trilogy Sales: $789 million for the quarter, a 17% increase.Collaboration Revenue: $16.9 million, an 8% increase compared to last year.Hospital Doses: 227,000 doses shipped, a 40% increase compared to Q3 2023.Cash Position: $91 million at the end of the period.Operating Expenses: G&A expenses decreased by 7% in the quarter and 21% year-to-date.Share-Based Compensation: $5 million for the quarter, a 21% reduction compared to last year.Non-Cash Impairment Charge: $1.6 million due to the write-down of operating lease assets.GuruFocus has detected 3 Warning Signs with TBPH.Theravance Biopharma Inc  reported a 7% year-over-year growth in net sales, reaching an all-time high of $62.2 million.GSK delivered strong Trilogy sales, reaching $789 million for the quarter, positioning Theravance Biopharma Inc  to achieve a $50 million sales milestone.Q: What is driving the 40% year-over-year increase i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/q2DS.ftIof9sk2m6g5ZFUQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ee382818ed732c4b3ec0ada1fa7b8afc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/q2DS.ftIof9sk2m6g5ZFUQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ee382818ed732c4b3ec0ada1fa7b8afc"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-inc-tbph-q3-072213375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH"],"gpt_icon":0},{"id":"2483045360","title":"Balanced View on Theravance Biopharma: Strong Growth Amidst Financial Challenges and Strategic Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2483045360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483045360?lang=en_us&edition=fundamental","pubTime":"2024-11-13 13:05","pubTimestamp":1731474324,"startTime":"0","endTime":"0","summary":"Analyst Marc Frahm of TD Cowen maintained a Hold rating on Theravance Biopharma (TBPH – Research Report), with a price target of $9.00. Marc Frahm’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/balanced-view-on-theravance-biopharma-strong-growth-amidst-financial-challenges-and-strategic-uncertainty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/balanced-view-on-theravance-biopharma-strong-growth-amidst-financial-challenges-and-strategic-uncertainty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2483009875","title":"Theravance Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483009875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483009875?lang=en_us&edition=fundamental","pubTime":"2024-11-13 08:08","pubTimestamp":1731456522,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc reports results for the quarter ended September 30 - Earnings SummaryTheravance Biopharma Inc TBPH.OQ reported a quarterly adjusted loss of 26 cents per share for the quarter ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL8N3MK03Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2483094963","title":"Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483094963","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483094963?lang=en_us&edition=fundamental","pubTime":"2024-11-13 07:05","pubTimestamp":1731452721,"startTime":"0","endTime":"0","summary":"Theravance Biopharma  came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.09 per share when it actually produced a loss of $0.13, delivering a surprise of -44.44%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Theravance Bio , which belongs to the Zacks Medical - Drugs industry, posted revenues of $16.87 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 4.71%. This compares to year-ago revenues of $15.69 million. The company has topped consensus revenue estimates two times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-tbph-reports-q3-230521861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH"],"gpt_icon":0},{"id":"2483574630","title":"Theravance Biopharma Q3 2024 Adj. EPS $(0.26) Misses $(0.23) Estimate, Sales $16.900M Beat $15.344M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483574630","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483574630?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:22","pubTimestamp":1731446562,"startTime":"0","endTime":"0","summary":"Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.23) by 13.04 percent.  The company reported quarterly sales of $16.900 million which","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41920050/theravance-biopharma-q3-2024-adj-eps-0-26-misses-0-23-estimate-sales-16-900m-beat-15-344m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Theravance Biopharma Q3 2024 Adj. EPS $(0.26) Misses $(0.23) Estimate, Sales $16.900M Beat $15.344M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2483972052","title":"BRIEF-Theravance Biopharma Q3 Operating Income USD -10.837 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483972052","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483972052?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445550,"startTime":"0","endTime":"0","summary":"BRIEF-Theravance Biopharma Q3 Operating Income USD -10.837 Million\n\n\nNov 12 (Reuters) - Theravance Biopharma Q3 net income USD -12.698 million.\n\nQ3 adjusted net income USD -2.897 million vs. IBES estimate USD -11.2 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nPLX97AC8C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2483838052","title":"Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2483838052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483838052?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA7HNVY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2482753202","title":"Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2482753202","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482753202?lang=en_us&edition=fundamental","pubTime":"2024-11-11 23:46","pubTimestamp":1731339960,"startTime":"0","endTime":"0","summary":"The third-quarter 2024 reporting cycle of the Medicalsector is about to end as most firms have already reported their earnings results. The sector mainly comprises pharma/biotech and medical device companies. The earnings season for the drug and biotech sector kicked off around mid-October when bellwether Johnson & Johnson reported strongthird-quarter results, beating estimates for earnings and sales. J&J consequently raised its total revenue expectation for the year while lowering its adjusted earnings expectation.Among other pharma bigwigs, Novartis also beatthird-quarter earnings and revenue estimates, driven by a year-over-year increase in sales of key drugs. Based on strong momentum, Novartis raised its sales guidance for the year. However, Novo Nordisk, a market leader in diabetes and obesity care medicines, failedto meet investor expectations in the reported quarter, despite higher product sales. Eli Lilly also missedearnings and revenue estimates in the third quarter and lowere","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-biotech-stocks-surpass-q3-154600159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AZN","NVAX","TBPH","PRTA"],"gpt_icon":0},{"id":"2482738190","title":"Zacks Industry Outlook Madrigal, Corcept, Catalyst  Larimar and  Theravance","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738190","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482738190?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:47","pubTimestamp":1731329220,"startTime":"0","endTime":"0","summary":"Chicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics LRMR and Theravance Biopharma TBPH.The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act . With Donald Trump’s reelection, the biotech industry hopes to witness more innovation and mergers and acquisitions (M&A) activity. Efforts to repeal the IRA look likely.However, it all depends on who is appointed to key roles at federal health agencies. Drug pricing reforms are expected to remain a key priority for the new government. Trump, in his previous term, had put stress on control of drug prices, though it was not highlighted in his election campaign this time around. Regular pipeline setbacks, slow ramp-up of newer drugs, Federal Trade Commission’s  scrutiny of M&A deals and broader macroeconomic uncertainty are some of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rP1EV4y5.bnG6Q.bCrRgNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rP1EV4y5.bnG6Q.bCrRgNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-industry-outlook-madrigal-corcept-124700319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","LU0566484027.USD","UPRO","SDS","OEF","BK4539","BK4504","MDGL","ESmain","BK4532","BK4588","BK4130","FTC","LRMR","SH","BK4585","BK4559",".SPX","CPRX","SPXU","LU1559883803.SGD","TBPH","VOO","FA","BK4139","SPY","BK4534","SSO","BK4535","BK4007","OEX","IVV","CORT","BK4581"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-26","symbol":"TBPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-11-12","symbol":"TBPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-08-05","symbol":"TBPH","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-05-13","symbol":"TBPH","fiscalQuarterEnding":"2024/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2024-02-26","symbol":"TBPH","fiscalQuarterEnding":"2023/12","expectedEps":-0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1708923600000,"reportTimeType":"post","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1723003200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TBPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TBPH","date":"2025-04-22","current":-8.005725,"percent":0.236304,"low":-10.895737,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"high":0.904616,"avg":-4.648481,"sd":3.420294,"marketCap":451667007},"quantilePoints":[{"date":"2020-04-24","current":-8.067961,"twenty":-8.083658,"median":-5.628892,"eighty":-3.969329,"marketCap":1907709674},{"date":"2020-05-01","current":-7.127409,"twenty":-8.104143,"median":-5.662817,"eighty":-3.97135,"marketCap":1685311551},{"date":"2020-05-08","current":-7.174216,"twenty":-8.104143,"median":-5.688858,"eighty":-4.025458,"marketCap":1771514718},{"date":"2020-05-15","current":-7.003036,"twenty":-8.104143,"median":-5.702965,"eighty":-4.061913,"marketCap":1729245670},{"date":"2020-05-22","current":-6.995371,"twenty":-8.104143,"median":-5.716143,"eighty":-4.11164,"marketCap":1727353026},{"date":"2020-05-29","current":-6.451173,"twenty":-8.104143,"median":-5.736387,"eighty":-4.131774,"marketCap":1592975307},{"date":"2020-06-05","current":-6.601914,"twenty":-8.104143,"median":-5.762244,"eighty":-4.178503,"marketCap":1630197305},{"date":"2020-06-12","current":-6.451173,"twenty":-8.104143,"median":-5.769353,"eighty":-4.198886,"marketCap":1592975307},{"date":"2020-06-19","current":-5.588888,"twenty":-8.104143,"median":-5.773576,"eighty":-4.218777,"marketCap":1380052865},{"date":"2020-06-26","current":-5.367887,"twenty":-8.104143,"median":-5.773576,"eighty":-4.252681,"marketCap":1325481632},{"date":"2020-07-02","current":-5.242696,"twenty":-8.104143,"median":-5.773576,"eighty":-4.267317,"marketCap":1294568448},{"date":"2020-07-10","current":-5.523737,"twenty":-8.104143,"median":-5.773576,"eighty":-4.291364,"marketCap":1363965392},{"date":"2020-07-17","current":-5.669368,"twenty":-8.104143,"median":-5.773576,"eighty":-4.331101,"marketCap":1399925626},{"date":"2020-07-24","current":-5.301459,"twenty":-8.104143,"median":-5.773576,"eighty":-4.364331,"marketCap":1309078718},{"date":"2020-07-31","current":-4.961655,"twenty":-8.104143,"median":-5.773576,"eighty":-4.382367,"marketCap":1225171504},{"date":"2020-08-07","current":-4.196887,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1133062832},{"date":"2020-08-14","current":-3.92888,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1060707347},{"date":"2020-08-21","current":-4.341766,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1172176891},{"date":"2020-08-28","current":-4.074743,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1100086901},{"date":"2020-09-04","current":-4.065126,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1097490399},{"date":"2020-09-11","current":-3.996426,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1078943067},{"date":"2020-09-18","current":-4.221477,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1139701568},{"date":"2020-09-25","current":-3.723996,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1005393303},{"date":"2020-10-02","current":-3.548694,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":958065628},{"date":"2020-10-09","current":-4.264118,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1151213706},{"date":"2020-10-16","current":-4.389672,"twenty":-8.104143,"median":-5.773576,"eighty":-4.391068,"marketCap":1185110554},{"date":"2020-10-23","current":-4.607616,"twenty":-8.104143,"median":-5.773576,"eighty":-4.400195,"marketCap":1243950365},{"date":"2020-10-30","current":-4.479693,"twenty":-8.104143,"median":-5.773576,"eighty":-4.421814,"marketCap":1209413954},{"date":"2020-11-06","current":-3.765315,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1073826562},{"date":"2020-11-13","current":-3.961969,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1129910058},{"date":"2020-11-20","current":-3.861013,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1101118465},{"date":"2020-11-27","current":-3.681535,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1049933411},{"date":"2020-12-04","current":-3.825118,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1090881454},{"date":"2020-12-11","current":-4.175099,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1190692309},{"date":"2020-12-18","current":-4.365794,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1245076428},{"date":"2020-12-24","current":-4.208751,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1200289506},{"date":"2020-12-31","current":-3.986647,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1136948003},{"date":"2021-01-08","current":-3.961969,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1129910058},{"date":"2021-01-15","current":-4.036004,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1151023892},{"date":"2021-01-22","current":-4.067412,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1159981277},{"date":"2021-01-29","current":-4.181829,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1192611748},{"date":"2021-02-05","current":-4.464507,"twenty":-8.104143,"median":-5.773576,"eighty":-4.427269,"marketCap":1273228208},{"date":"2021-02-12","current":-4.410663,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1257872692},{"date":"2021-02-19","current":-4.215481,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1202208946},{"date":"2021-02-26","current":-3.833982,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1065912143},{"date":"2021-03-05","current":-4.500359,"twenty":-8.109294,"median":-5.774844,"eighty":-4.440716,"marketCap":1251176293},{"date":"2021-03-12","current":-4.775702,"twenty":-8.109294,"median":-5.774844,"eighty":-4.454509,"marketCap":1327726411},{"date":"2021-03-19","current":-4.87751,"twenty":-8.109294,"median":-5.774844,"eighty":-4.466582,"marketCap":1356030656},{"date":"2021-03-26","current":-4.80658,"twenty":-8.104143,"median":-5.773576,"eighty":-4.479554,"marketCap":1336310980},{"date":"2021-04-01","current":-4.719785,"twenty":-8.104143,"median":-5.773576,"eighty":-4.486573,"marketCap":1312180425},{"date":"2021-04-09","current":-4.914488,"twenty":-8.109294,"median":-5.774844,"eighty":-4.505471,"marketCap":1366311129},{"date":"2021-04-16","current":-5.09277,"twenty":-8.109294,"median":-5.774844,"eighty":-4.507772,"marketCap":1415876592},{"date":"2021-04-23","current":-4.961404,"twenty":-8.109294,"median":-5.774844,"eighty":-4.519721,"marketCap":1379354672},{"date":"2021-04-30","current":-4.630644,"twenty":-8.109294,"median":-5.774844,"eighty":-4.543546,"marketCap":1287397694},{"date":"2021-05-07","current":-4.694319,"twenty":-8.109294,"median":-5.774844,"eighty":-4.555614,"marketCap":1289261968},{"date":"2021-05-14","current":-4.449502,"twenty":-8.109294,"median":-5.774844,"eighty":-4.55769,"marketCap":1222024508},{"date":"2021-05-21","current":-4.145262,"twenty":-8.109294,"median":-5.774844,"eighty":-4.55769,"marketCap":1138467277},{"date":"2021-05-28","current":-4.107232,"twenty":-8.109294,"median":-5.774844,"eighty":-4.54777,"marketCap":1128022623},{"date":"2021-06-04","current":-3.938475,"twenty":-8.109294,"median":-5.774844,"eighty":-4.533645,"marketCap":1081674471},{"date":"2021-06-11","current":-4.325904,"twenty":-8.109294,"median":-5.774844,"eighty":-4.513199,"marketCap":1188079383},{"date":"2021-06-18","current":-4.164277,"twenty":-8.109294,"median":-5.774844,"eighty":-4.505684,"marketCap":1143689604},{"date":"2021-06-25","current":-4.085012,"twenty":-8.109294,"median":-5.774844,"eighty":-4.486884,"marketCap":1121919864},{"date":"2021-07-02","current":-3.762924,"twenty":-8.109294,"median":-5.774844,"eighty":-4.481775,"marketCap":1033460797},{"date":"2021-07-09","current":-3.590097,"twenty":-8.109294,"median":-5.774844,"eighty":-4.472621,"marketCap":985994957},{"date":"2021-07-16","current":-3.47226,"twenty":-8.109294,"median":-5.774844,"eighty":-4.457472,"marketCap":953631884},{"date":"2021-07-23","current":-3.553436,"twenty":-8.109294,"median":-5.774844,"eighty":-4.449502,"marketCap":975926445},{"date":"2021-07-30","current":-3.398939,"twenty":-8.109294,"median":-5.774844,"eighty":-4.430832,"marketCap":933494861},{"date":"2021-08-06","current":-3.615643,"twenty":-8.109294,"median":-5.772308,"eighty":-4.424502,"marketCap":955111963},{"date":"2021-08-13","current":-3.760269,"twenty":-8.109294,"median":-5.764166,"eighty":-4.416356,"marketCap":993316441},{"date":"2021-08-20","current":-3.907676,"twenty":-8.109294,"median":-5.757271,"eighty":-4.403183,"marketCap":1032255621},{"date":"2021-08-27","current":-2.28898,"twenty":-8.109294,"median":-5.730996,"eighty":-4.390152,"marketCap":604659342},{"date":"2021-09-03","current":-2.355731,"twenty":-8.109294,"median":-5.714021,"eighty":-4.38615,"marketCap":622292178},{"date":"2021-09-10","current":-2.352949,"twenty":-8.109294,"median":-5.703573,"eighty":-4.378008,"marketCap":621557477},{"date":"2021-09-17","current":-1.977479,"twenty":-8.109294,"median":-5.688858,"eighty":-4.365944,"marketCap":522372773},{"date":"2021-09-24","current":-1.952447,"twenty":-8.074271,"median":-5.669407,"eighty":-4.356033,"marketCap":515760460},{"date":"2021-10-01","current":-2.069261,"twenty":-8.045944,"median":-5.638655,"eighty":-4.341342,"marketCap":546617923},{"date":"2021-10-08","current":-2.280637,"twenty":-8.016163,"median":-5.625476,"eighty":-4.330717,"marketCap":602455238},{"date":"2021-10-15","current":-2.22223,"twenty":-7.997331,"median":-5.608563,"eighty":-4.307524,"marketCap":587026506},{"date":"2021-10-22","current":-2.147136,"twenty":-7.997331,"median":-5.5825,"eighty":-4.289657,"marketCap":567189565},{"date":"2021-10-29","current":-2.161042,"twenty":-7.997331,"median":-5.562665,"eighty":-4.280637,"marketCap":570863073},{"date":"2021-11-05","current":-2.944324,"twenty":-7.997331,"median":-5.541795,"eighty":-4.270191,"marketCap":664904866},{"date":"2021-11-12","current":-2.676073,"twenty":-7.97491,"median":-5.530125,"eighty":-4.26185,"marketCap":604326781},{"date":"2021-11-19","current":-2.728289,"twenty":-7.915096,"median":-5.521827,"eighty":-4.240905,"marketCap":616118523},{"date":"2021-11-26","current":-2.614066,"twenty":-7.915096,"median":-5.494408,"eighty":-4.224725,"marketCap":590324087},{"date":"2021-12-03","current":-2.535742,"twenty":-7.915096,"median":-5.486755,"eighty":-4.218356,"marketCap":572636474},{"date":"2021-12-10","current":-3.178652,"twenty":-7.905554,"median":-5.462928,"eighty":-4.210236,"marketCap":717822299},{"date":"2021-12-17","current":-3.508266,"twenty":-7.863621,"median":-5.43799,"eighty":-4.192263,"marketCap":792257671},{"date":"2021-12-23","current":-3.518056,"twenty":-7.79203,"median":-5.430638,"eighty":-4.183439,"marketCap":794468622},{"date":"2021-12-31","current":-3.606171,"twenty":-7.706812,"median":-5.421098,"eighty":-4.174698,"marketCap":814367187},{"date":"2022-01-07","current":-4.2295,"twenty":-7.490651,"median":-5.415781,"eighty":-4.171972,"marketCap":955131108},{"date":"2022-01-14","current":-3.224341,"twenty":-7.39119,"median":-5.403277,"eighty":-4.154162,"marketCap":728140073},{"date":"2022-01-21","current":-2.738079,"twenty":-7.283381,"median":-5.391459,"eighty":-4.143836,"marketCap":618329475},{"date":"2022-01-28","current":-2.858829,"twenty":-7.255155,"median":-5.375582,"eighty":-4.130131,"marketCap":645597878},{"date":"2022-02-04","current":-2.881673,"twenty":-7.164617,"median":-5.360998,"eighty":-4.115812,"marketCap":650756766},{"date":"2022-02-11","current":-3.005686,"twenty":-7.129748,"median":-5.345665,"eighty":-4.106391,"marketCap":678762153},{"date":"2022-02-18","current":-3.136227,"twenty":-7.086122,"median":-5.318068,"eighty":-4.092363,"marketCap":708241508},{"date":"2022-02-25","current":-3.784218,"twenty":-7.055237,"median":-5.296367,"eighty":-4.074174,"marketCap":754671493},{"date":"2022-03-04","current":-3.599506,"twenty":-6.986071,"median":-5.279742,"eighty":-4.064449,"marketCap":717835162},{"date":"2022-03-11","current":-3.704383,"twenty":-6.907174,"median":-5.270085,"eighty":-4.051495,"marketCap":738750234},{"date":"2022-03-18","current":-3.917881,"twenty":-6.883977,"median":-5.238484,"eighty":-4.041607,"marketCap":781327346},{"date":"2022-03-25","current":-3.695631,"twenty":-6.821381,"median":-5.213693,"eighty":-4.033509,"marketCap":737004982},{"date":"2022-04-01","current":-3.600481,"twenty":-6.748055,"median":-5.173949,"eighty":-4.023592,"marketCap":718029571},{"date":"2022-04-08","current":-3.707049,"twenty":-6.708949,"median":-5.154002,"eighty":-4.012509,"marketCap":739282032},{"date":"2022-04-14","current":-3.779363,"twenty":-6.646559,"median":-5.123213,"eighty":-4.006133,"marketCap":753703344},{"date":"2022-04-22","current":-3.486301,"twenty":-6.620365,"median":-5.107869,"eighty":-3.983031,"marketCap":695259077},{"date":"2022-04-29","current":-3.672795,"twenty":-6.58534,"median":-5.089808,"eighty":-3.961969,"marketCap":732450883},{"date":"2022-05-06","current":-4.869112,"twenty":-6.539981,"median":-5.065962,"eighty":-3.95749,"marketCap":709395462},{"date":"2022-05-13","current":-4.764624,"twenty":-6.488349,"median":-5.043541,"eighty":-3.95749,"marketCap":694172384},{"date":"2022-05-20","current":-4.566098,"twenty":-6.452269,"median":-5.004378,"eighty":-3.95749,"marketCap":665248534},{"date":"2022-05-27","current":-4.827317,"twenty":-6.407665,"median":-4.988003,"eighty":-3.95749,"marketCap":703306231},{"date":"2022-06-03","current":-4.733278,"twenty":-6.37586,"median":-4.971167,"eighty":-3.95749,"marketCap":689605460},{"date":"2022-06-10","current":-4.482508,"twenty":-6.338788,"median":-4.96153,"eighty":-3.95749,"marketCap":653070071},{"date":"2022-06-17","current":-4.539976,"twenty":-6.300389,"median":-4.946484,"eighty":-3.95749,"marketCap":661442765},{"date":"2022-06-24","current":-4.696707,"twenty":-6.267019,"median":-4.910906,"eighty":-3.95749,"marketCap":684277383},{"date":"2022-07-01","current":-5.083311,"twenty":-6.240179,"median":-4.890862,"eighty":-3.95749,"marketCap":740602773},{"date":"2022-07-08","current":-4.822092,"twenty":-6.216799,"median":-4.87956,"eighty":-3.95749,"marketCap":702545077},{"date":"2022-07-15","current":-4.581771,"twenty":-6.209146,"median":-4.869112,"eighty":-3.95749,"marketCap":667531996},{"date":"2022-07-22","current":-5.062413,"twenty":-6.191017,"median":-4.862682,"eighty":-3.95749,"marketCap":737558158},{"date":"2022-07-29","current":-4.59222,"twenty":-6.179545,"median":-4.82892,"eighty":-3.95749,"marketCap":669054304},{"date":"2022-08-05","current":-6.555529,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":665248534},{"date":"2022-08-12","current":-7.237614,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":734465814},{"date":"2022-08-19","current":-7.034268,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":713830458},{"date":"2022-08-26","current":-6.815859,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":691666558},{"date":"2022-09-02","current":-7.056862,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":716123276},{"date":"2022-09-09","current":-6.906235,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":700837827},{"date":"2022-09-16","current":-7.584055,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":769622347},{"date":"2022-09-23","current":-7.523805,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":763508167},{"date":"2022-09-30","current":-6.731347,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":683090347},{"date":"2022-10-07","current":-6.578663,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":667596187},{"date":"2022-10-14","current":-6.585302,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":668269847},{"date":"2022-10-21","current":-6.532195,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":662880574},{"date":"2022-10-28","current":-6.631771,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":672985460},{"date":"2022-11-04","current":-6.611855,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":670964483},{"date":"2022-11-11","current":0.89271,"twenty":-6.146499,"median":-4.820655,"eighty":-3.940021,"marketCap":759213828},{"date":"2022-11-18","current":0.859441,"twenty":-6.127876,"median":-4.801195,"eighty":-3.931298,"marketCap":730920145},{"date":"2022-11-25","current":0.838193,"twenty":-6.120221,"median":-4.790159,"eighty":-3.924806,"marketCap":712849417},{"date":"2022-12-02","current":0.871404,"twenty":-6.112485,"median":-4.781893,"eighty":-3.907695,"marketCap":741094393},{"date":"2022-12-09","current":0.857961,"twenty":-6.085916,"median":-4.773739,"eighty":-3.868192,"marketCap":729661903},{"date":"2022-12-16","current":0.86745,"twenty":-6.066767,"median":-4.764624,"eighty":-3.84486,"marketCap":737731896},{"date":"2022-12-23","current":0.893545,"twenty":-6.05758,"median":-4.750843,"eighty":-3.819542,"marketCap":759924378},{"date":"2022-12-30","current":0.887219,"twenty":-6.047108,"median":-4.743423,"eighty":-3.802491,"marketCap":754544382},{"date":"2023-01-06","current":0.885638,"twenty":-6.047108,"median":-4.728054,"eighty":-3.791192,"marketCap":753199384},{"date":"2023-01-13","current":0.893545,"twenty":-6.047108,"median":-4.715093,"eighty":-3.772761,"marketCap":759924378},{"date":"2023-01-20","current":0.877335,"twenty":-6.047108,"median":-4.707156,"eighty":-3.760269,"marketCap":746138139},{"date":"2023-01-27","current":0.859543,"twenty":-6.044599,"median":-4.691483,"eighty":-3.742884,"marketCap":731006902},{"date":"2023-02-03","current":0.842147,"twenty":-6.044599,"median":-4.686259,"eighty":-3.723165,"marketCap":716211914},{"date":"2023-02-10","current":0.820796,"twenty":-6.044599,"median":-4.676099,"eighty":-3.710822,"marketCap":698054429},{"date":"2023-02-17","current":0.825541,"twenty":-6.044599,"median":-4.655962,"eighty":-3.702405,"marketCap":702089425},{"date":"2023-02-24","current":0.780468,"twenty":-6.044599,"median":-4.653259,"eighty":-3.691816,"marketCap":663756957},{"date":"2023-03-03","current":0.725859,"twenty":-6.044599,"median":-4.644464,"eighty":-3.673453,"marketCap":633045253},{"date":"2023-03-10","current":0.736672,"twenty":-6.044599,"median":-4.630524,"eighty":-3.653022,"marketCap":642474924},{"date":"2023-03-17","current":0.738834,"twenty":-6.044599,"median":-4.621402,"eighty":-3.638541,"marketCap":644360858},{"date":"2023-03-24","current":0.758296,"twenty":-6.044599,"median":-4.613117,"eighty":-3.627973,"marketCap":661334266},{"date":"2023-03-31","current":0.786576,"twenty":-6.04375,"median":-4.605891,"eighty":-3.615693,"marketCap":685997879},{"date":"2023-04-06","current":0.803975,"twenty":-6.04375,"median":-4.603005,"eighty":-3.605794,"marketCap":701172025},{"date":"2023-04-14","current":0.863421,"twenty":-6.044599,"median":-4.603005,"eighty":-3.587389,"marketCap":753017027},{"date":"2023-04-21","current":0.835873,"twenty":-6.044599,"median":-4.603005,"eighty":-3.563925,"marketCap":728991294},{"date":"2023-04-28","current":0.783676,"twenty":-6.044599,"median":-4.597235,"eighty":-3.536548,"marketCap":683468854},{"date":"2023-05-05","current":0.814849,"twenty":-6.044599,"median":-4.596353,"eighty":-3.51414,"marketCap":710655867},{"date":"2023-05-12","current":0.765928,"twenty":-6.044599,"median":-4.585694,"eighty":-3.495212,"marketCap":670945000},{"date":"2023-05-19","current":0.718518,"twenty":-6.044599,"median":-4.581354,"eighty":-3.485421,"marketCap":629414426},{"date":"2023-05-26","current":0.728415,"twenty":-6.044599,"median":-4.581354,"eighty":-3.453986,"marketCap":638084046},{"date":"2023-06-01","current":0.737652,"twenty":-6.044599,"median":-4.571181,"eighty":-3.439329,"marketCap":646175692},{"date":"2023-06-16","current":0.685528,"twenty":-6.047145,"median":-4.556078,"eighty":-3.259587,"marketCap":600515692},{"date":"2023-06-22","current":0.704002,"twenty":-6.047145,"median":-4.547581,"eighty":-3.182568,"marketCap":616698983},{"date":"2023-06-27","current":0.676291,"twenty":-6.047145,"median":-4.545402,"eighty":-3.136227,"marketCap":592424047},{"date":"2023-07-07","current":0.67761,"twenty":-6.047256,"median":-4.542588,"eighty":-3.012213,"marketCap":593579996},{"date":"2023-07-14","current":0.649899,"twenty":-6.047256,"median":-4.522012,"eighty":-2.971093,"marketCap":569305059},{"date":"2023-07-21","current":0.636703,"twenty":-6.047256,"median":-4.50904,"eighty":-2.924751,"marketCap":557745566},{"date":"2023-07-28","current":0.634724,"twenty":-6.047256,"median":-4.503406,"eighty":-2.867967,"marketCap":556011642},{"date":"2023-08-04","current":0.654518,"twenty":-6.047256,"median":-4.48687,"eighty":-2.794864,"marketCap":573350882},{"date":"2023-08-11","current":0.609287,"twenty":-6.045447,"median":-4.479345,"eighty":-2.74787,"marketCap":529187302},{"date":"2023-08-18","current":0.585572,"twenty":-6.045447,"median":-4.462624,"eighty":-2.728289,"marketCap":508590191},{"date":"2023-08-25","current":0.575235,"twenty":-6.045447,"median":-4.449502,"eighty":-2.674115,"marketCap":499611963},{"date":"2023-09-01","current":0.578883,"twenty":-6.033007,"median":-4.428611,"eighty":-2.593833,"marketCap":502780750},{"date":"2023-09-08","current":0.589828,"twenty":-6.016567,"median":-4.420338,"eighty":-2.539658,"marketCap":512287108},{"date":"2023-09-15","current":0.590436,"twenty":-5.994874,"median":-4.403007,"eighty":-2.392444,"marketCap":512815239},{"date":"2023-09-22","current":0.547871,"twenty":-5.980167,"median":-4.390072,"eighty":-2.342937,"marketCap":475846067},{"date":"2023-09-29","current":0.509563,"twenty":-5.971921,"median":-4.382328,"eighty":-2.283974,"marketCap":442573811},{"date":"2023-10-06","current":0.550912,"twenty":-5.945804,"median":-4.367183,"eighty":-2.22223,"marketCap":478486722},{"date":"2023-10-13","current":0.558209,"twenty":-5.937293,"median":-4.348344,"eighty":-2.190524,"marketCap":484824294},{"date":"2023-10-20","current":0.545439,"twenty":-5.919911,"median":-4.338527,"eighty":-2.170498,"marketCap":473733542},{"date":"2023-10-27","current":0.561857,"twenty":-5.91888,"median":-4.325904,"eighty":-2.158261,"marketCap":487993080},{"date":"2023-11-03","current":0.594693,"twenty":-5.91888,"median":-4.301844,"eighty":-2.068148,"marketCap":516512157},{"date":"2023-11-10","current":-8.790683,"twenty":-5.931389,"median":-4.294914,"eighty":-2.058135,"marketCap":501464510},{"date":"2023-11-17","current":-8.982734,"twenty":-5.941785,"median":-4.294914,"eighty":-2.058135,"marketCap":512420041},{"date":"2023-11-24","current":-9.139866,"twenty":-5.951889,"median":-4.294914,"eighty":-2.058135,"marketCap":521383657},{"date":"2023-12-01","current":-9.148596,"twenty":-5.974498,"median":-4.294914,"eighty":-2.058135,"marketCap":521881635},{"date":"2023-12-08","current":-9.25335,"twenty":-5.976931,"median":-4.29496,"eighty":-2.058135,"marketCap":527857379},{"date":"2023-12-15","current":-9.611263,"twenty":-5.982249,"median":-4.29496,"eighty":-2.058135,"marketCap":548274504},{"date":"2023-12-22","current":-9.89061,"twenty":-6.037727,"median":-4.29496,"eighty":-2.058135,"marketCap":564209821},{"date":"2023-12-29","current":-9.87315,"twenty":-6.055696,"median":-4.294914,"eighty":-2.058135,"marketCap":563213864},{"date":"2024-01-05","current":-10.056471,"twenty":-6.065646,"median":-4.293344,"eighty":-2.058135,"marketCap":573671416},{"date":"2024-01-12","current":-8.537525,"twenty":-6.075519,"median":-4.293344,"eighty":-2.058135,"marketCap":487023129},{"date":"2024-01-19","current":-8.310556,"twenty":-6.115014,"median":-4.291775,"eighty":-2.058135,"marketCap":474075684},{"date":"2024-01-26","current":-8.65101,"twenty":-6.124513,"median":-4.293344,"eighty":-2.058135,"marketCap":493496852},{"date":"2024-02-02","current":-7.996292,"twenty":-6.153311,"median":-4.293344,"eighty":-2.058135,"marketCap":456148452},{"date":"2024-02-09","current":-7.175711,"twenty":-6.191017,"median":-4.293344,"eighty":-2.058135,"marketCap":409338458},{"date":"2024-02-16","current":-7.568542,"twenty":-6.210395,"median":-4.293344,"eighty":-2.058135,"marketCap":431747498},{"date":"2024-02-23","current":-7.572907,"twenty":-6.222321,"median":-4.293344,"eighty":-2.058135,"marketCap":431996487},{"date":"2024-03-01","current":-8.252985,"twenty":-6.244375,"median":-4.294914,"eighty":-2.058135,"marketCap":455507000},{"date":"2024-03-08","current":-7.583413,"twenty":-6.26237,"median":-4.294914,"eighty":-2.058135,"marketCap":418551312},{"date":"2024-03-15","current":-7.5136,"twenty":-6.300389,"median":-4.294914,"eighty":-2.058135,"marketCap":414698135},{"date":"2024-03-22","current":-7.819031,"twenty":-6.378281,"median":-4.294914,"eighty":-2.058135,"marketCap":431555783},{"date":"2024-03-28","current":-7.862664,"twenty":-6.418847,"median":-4.294914,"eighty":-2.058135,"marketCap":433964019},{"date":"2024-04-05","current":-7.97611,"twenty":-6.461522,"median":-4.293344,"eighty":-2.058135,"marketCap":440225431},{"date":"2024-04-12","current":-7.856801,"twenty":-6.51133,"median":-4.293344,"eighty":-2.058135,"marketCap":433640398},{"date":"2024-04-19","current":-8.094352,"twenty":-6.533511,"median":-4.293344,"eighty":-2.058135,"marketCap":446751586},{"date":"2024-04-26","current":-8.041563,"twenty":-6.555878,"median":-4.294914,"eighty":-2.058135,"marketCap":443837988},{"date":"2024-05-03","current":-8.243922,"twenty":-6.57917,"median":-4.294914,"eighty":-2.058135,"marketCap":455006778},{"date":"2024-05-10","current":-8.331904,"twenty":-6.603902,"median":-4.294914,"eighty":-2.058135,"marketCap":459862773},{"date":"2024-05-17","current":-10.428621,"twenty":-6.620365,"median":-4.294914,"eighty":-2.058135,"marketCap":466878950},{"date":"2024-05-24","current":-9.287991,"twenty":-6.638909,"median":-4.294914,"eighty":-2.058135,"marketCap":415814065},{"date":"2024-05-31","current":-9.222812,"twenty":-6.650555,"median":-4.295005,"eighty":-2.058135,"marketCap":412896071},{"date":"2024-06-07","current":-9.646475,"twenty":-6.694809,"median":-4.325904,"eighty":-2.058135,"marketCap":431863029},{"date":"2024-06-14","current":-9.32058,"twenty":-6.714869,"median":-4.341236,"eighty":-2.058135,"marketCap":417273061},{"date":"2024-06-21","current":-9.407486,"twenty":-6.729069,"median":-4.351769,"eighty":-2.058135,"marketCap":421163719},{"date":"2024-06-28","current":-9.049002,"twenty":-6.740828,"median":-4.365284,"eighty":-2.052016,"marketCap":405114755},{"date":"2024-07-05","current":-9.244538,"twenty":-6.781753,"median":-4.377444,"eighty":-2.052016,"marketCap":413868736},{"date":"2024-07-12","current":-10.135316,"twenty":-6.814349,"median":-4.384999,"eighty":-2.052016,"marketCap":453747979},{"date":"2024-07-15","current":-10.178769,"twenty":-6.816504,"median":-4.387059,"eighty":-2.052016,"marketCap":455693308},{"date":"2024-08-02","current":-10.895737,"twenty":-6.836947,"median":-4.368573,"eighty":-1.983598,"marketCap":487791236},{"date":"2024-08-09","current":-8.18135,"twenty":-6.880736,"median":-4.368573,"eighty":-1.983598,"marketCap":373503160},{"date":"2024-08-16","current":-8.840759,"twenty":-6.897996,"median":-4.368573,"eighty":-1.983598,"marketCap":403607184},{"date":"2024-08-23","current":-8.583574,"twenty":-6.949119,"median":-4.368573,"eighty":-1.983598,"marketCap":391865884},{"date":"2024-08-30","current":-8.797895,"twenty":-6.995146,"median":-4.368573,"eighty":-1.983598,"marketCap":401650301},{"date":"2024-09-06","current":-8.755031,"twenty":-7.046318,"median":-4.368573,"eighty":-1.983598,"marketCap":399693418},{"date":"2024-09-13","current":-8.690734,"twenty":-7.071924,"median":-4.368573,"eighty":-1.983598,"marketCap":396758093},{"date":"2024-09-20","current":-8.797895,"twenty":-7.099928,"median":-4.368573,"eighty":-1.983598,"marketCap":401650301},{"date":"2024-09-27","current":-8.637154,"twenty":-7.126973,"median":-4.368573,"eighty":-1.983598,"marketCap":394311988},{"date":"2024-10-04","current":-8.680018,"twenty":-7.161703,"median":-4.368573,"eighty":-1.983598,"marketCap":396268872},{"date":"2024-10-11","current":-8.637154,"twenty":-7.181652,"median":-4.368573,"eighty":-1.983598,"marketCap":394311988},{"date":"2024-10-18","current":-9.237254,"twenty":-7.281351,"median":-4.377727,"eighty":-1.983598,"marketCap":421708355},{"date":"2024-10-25","current":-9.258686,"twenty":-7.375637,"median":-4.389672,"eighty":-1.983598,"marketCap":422686797},{"date":"2024-10-31","current":-9.076513,"twenty":-7.418279,"median":-4.403886,"eighty":-1.983598,"marketCap":414370043},{"date":"2024-11-08","current":-9.376563,"twenty":-7.489976,"median":-4.428094,"eighty":-1.977479,"marketCap":428068226},{"date":"2024-11-15","current":-9.526083,"twenty":-7.523805,"median":-4.428611,"eighty":-1.977479,"marketCap":470598012},{"date":"2024-11-22","current":-9.565899,"twenty":-7.56596,"median":-4.428611,"eighty":-1.977479,"marketCap":472564984},{"date":"2024-11-29","current":-9.207551,"twenty":-7.583413,"median":-4.428611,"eighty":-1.977479,"marketCap":454862238},{"date":"2024-12-06","current":-9.794844,"twenty":-7.647109,"median":-4.428611,"eighty":-1.977479,"marketCap":483875072},{"date":"2024-12-13","current":-9.824706,"twenty":-7.697025,"median":-4.428611,"eighty":-1.977479,"marketCap":485350301},{"date":"2024-12-20","current":-9.685348,"twenty":-7.725675,"median":-4.428611,"eighty":-1.977479,"marketCap":478465900},{"date":"2024-12-27","current":-9.814752,"twenty":-7.784125,"median":-4.428611,"eighty":-1.977479,"marketCap":484858558},{"date":"2025-01-03","current":-9.237414,"twenty":-7.839159,"median":-4.428611,"eighty":-1.977479,"marketCap":456337466},{"date":"2025-01-10","current":-9.008469,"twenty":-7.86433,"median":-4.428611,"eighty":-1.976923,"marketCap":445027378},{"date":"2025-01-17","current":-8.401268,"twenty":-7.941203,"median":-4.428611,"eighty":-1.976923,"marketCap":415031058},{"date":"2025-01-24","current":-9.625624,"twenty":-8.016634,"median":-4.428611,"eighty":-1.976923,"marketCap":475515442},{"date":"2025-01-31","current":-9.625624,"twenty":-8.067959,"median":-4.428611,"eighty":-1.976923,"marketCap":475515442},{"date":"2025-02-07","current":-9.466358,"twenty":-8.136704,"median":-4.428611,"eighty":-1.976923,"marketCap":467647554},{"date":"2025-02-14","current":-9.436496,"twenty":-8.210314,"median":-4.428611,"eighty":-1.976923,"marketCap":466172326},{"date":"2025-02-21","current":-9.61567,"twenty":-8.252773,"median":-4.428611,"eighty":-1.976923,"marketCap":475023699},{"date":"2025-02-28","current":-8.133309,"twenty":-8.313066,"median":-4.428611,"eighty":-1.976923,"marketCap":458865000},{"date":"2025-03-07","current":-8.519356,"twenty":-8.326625,"median":-4.428094,"eighty":-1.976367,"marketCap":480645000},{"date":"2025-03-14","current":-8.137254,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":459087604},{"date":"2025-03-21","current":-8.207403,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":463045255},{"date":"2025-03-28","current":-8.16356,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":460571723},{"date":"2025-04-04","current":-7.690056,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":433857574},{"date":"2025-04-11","current":-7.356849,"twenty":-8.331904,"median":-4.428611,"eighty":-1.976923,"marketCap":415058728},{"date":"2025-04-17","current":-7.536606,"twenty":-8.331904,"median":-4.428611,"eighty":-1.976923,"marketCap":425200210},{"date":"2025-04-22","current":-8.005725,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":451667007}],"updateTime":1745431743316}}}